Disease/Infection News

RSS

Comprehensive H1N1 influenza health information centre launched in Canada

Canadians are seeking credible information concerning the H1N1 (human swine flu) virus. As a leading Canadian source of ealth information, www.medbroadcast.com has launched a one-stop comprehensive national H1N1 (human swine flu) Influenza Health information centre (www.medbroadcast.com/H1N1). This information centre will help meet the needs of Canadians in search of useful, credible, and accurate H1N1 information.

29 Oct 2009

AAHP confirms homeopathic medicines for prophylaxis of infectious diseases

Recent news articles regarding Swine Flu H1N1 have been widespread. The virulence of the strain among humans and its implications for pandemic disease in humans may lead to increased interest in homeopathic treatments for Swine Flu H1N1.

29 Oct 2009

NIH awards contract to LRRI for anthrax research

Lovelace Respiratory Research Institute (LRRI) was recently awarded a contract to continue research due to the potential for bioterrorist attacks involving Bacillus anthracis, the causative agent of anthrax, by the National Institutes of Allergy and Infectious Disease (NIAID), a division of the National Institutes of Health (NIH).

29 Oct 2009

Pregnant women with symptoms of depression have a stronger biological reaction to the seasonal flu vaccine

Pregnant women with significant symptoms of depression tend to have a stronger biological reaction to the seasonal flu vaccine than do women with lower depression levels, according to a new study.

29 Oct 2009

GE Healthcare to provide surveillance data for H1N1 and seasonal influenza activity throughout the U.S.

GE Healthcare, one of the leading providers of healthcare information technology, today announced its selection by the Centers for Disease Control and Prevention (CDC) to provide extensive surveillance data for H1N1 and seasonal influenza activity throughout the United States.

29 Oct 2009

$12.2 million grant from NIH for research on the sexually transmitted bacteria chlamydia

Perhaps the most comprehensive, multi-institutional study yet of the sexually transmitted bacteria chlamydia is under way at the University of Maryland, Baltimore (UMB).

29 Oct 2009

Scientists identify genetic mutations that may put individuals at increased risk of fungal infections

Two genetic mutations that may put individuals at increased risk of fungal infections have been identified by scientists from UCL and Radboud University, increasing understanding about the genetic basis of these infections and potentially aiding the development of new treatments.

29 Oct 2009

U.S. Department of Defense funds Rush University Medical Center for gastrointestinal microorganism research

The human body contains billions of microorganisms, and microbial cells found in the human gut are estimated to outnumber human cells by ten-to-one in healthy adults. However, little is known about the ways in which these minute life forms influence health and disease.

28 Oct 2009

NIH awards Excelimmune grant to develop treatment for Clostridium difficile infection

Excelimmune, Inc. (www.excelimmune.com) announced today that the National Institutes of Health (NIH) has awarded the company a Small Business Innovation Research (SBIR) grant to support research aimed at developing new treatments for Clostridium difficile (C. difficile) infection, employing Excelimmune’s expertise in developing novel antibody therapies for human disease.

28 Oct 2009

CDC says U.S. H1N1 vaccine supplies on the rise; Senators question government's handling of H1N1 vaccination program

Supplies of the H1N1 (swine flu) vaccine are steadily increasing in the U.S. and should soon be more widely accessible in the next two weeks, the CDC said on Tuesday, CQ HealthBeat reports. During a press briefing, CDC Director Thomas Frieden said that 22.4 million vaccine doses are now available for states to order (Norman, 10/27). "We're beginning to get to significant increases in the availability," Frieden said.

28 Oct 2009

Also in Global Health News: Germany HIV/AIDS grant; Sumatra water situation; India's unlicensed doctors; land ownership, food security

The Organisation for the Coordination of the Struggle Against Epidemics in Central Africa (OCEAC) on Tuesday announced that the German government has granted $34 million to help prevent the spread of HIV/AIDS in central Africa, Agence France-Presse reports.

28 Oct 2009

CDC: H1N1 vaccine supplies on the rise

"More than 22 million doses of swine flu vaccine are available now, and most Americans should soon find it easier to get their dose, U.S. health officials said Tuesday, " according to The Associated Press/The Washington Post.

28 Oct 2009

Lovelace Respiratory Research Institute and Brigham and Women's Hospital collaborate on respiratory diseases research

Lovelace Respiratory Research Institute (LRRI) recently announced the formation of a research agreement between the Division of Pulmonary and Critical Care Medicine of the Department of Medicine at Brigham and Women's Hospital (BWH), teaching hospital of Harvard Medical School in Boston.

28 Oct 2009

FDA approves the 100th antiretroviral drug in association with PEPFAR

The U.S. Department of Health and Human Services (HHS) today marked the recent approval of the 100th antiretroviral drug in association with the President's Emergency Plan for AIDS Relief (PEPFAR), aimed at the prevention, treatment, and care of people infected with and affected by HIV/AIDS worldwide.

28 Oct 2009

Innovative new partnership to provide free HIV testing and HIV/AIDS medical care in Saint-Petersburg

AIDS Healthcare Foundation (AHF), Saint-Petersburg Government Healthcare Institution’s Center for Prevention and Control of Infectious Diseases; AIDS, Statistics, Health, a respected regional non-governmental organization (NGO); and Saint-Petersburg Government Healthcare Institution’s Policlinic N109 are honored to announce that they are forming an innovative new partnership to provide free HIV testing and prevention services and HIV/AIDS medical care in Saint-Petersburg, Russia’s second largest city.

28 Oct 2009

Fastest supercomputer used to create an evolutionary genetic HIV family tree

Supporting Los Alamos National Laboratory's role in the international Center for HIV/AIDS Vaccine Immunology (CHAVI) consortium, researchers are using the Roadrunner supercomputer to analyze vast quantities of genetic sequences from HIV infected people in the hope of zeroing in on possible vaccine target areas.

28 Oct 2009

Dementia patients face higher risk of flu mortality; refine guidelines needed for testing and vaccination policies

An epidemiological study on pneumonia and influenza (P&I) in adults age 65 and over reports that patients with dementia are diagnosed with flu less frequently, have shorter hospital stays, and have a fifty percent higher rate of death than those without dementia.

28 Oct 2009

Researchers find link between foreskin and HIV infection

Randomized clinical trials conducted by researchers in Rakai, Uganda, have revealed a link between the size of foreskin surface area and the risk of male HIV acquisition.

28 Oct 2009

Toxic chemicals in face paints can cause skin sensitization and contact dermatitis

Ghosts and goblins aren't the only spooky things lurking around this Halloween. A new report by the Campaign for Safe Cosmetics reveals that popular children's face paints contain lead, a potent neurotoxin, as well as nickel, cobalt and chromium, which can cause lifelong skin sensitization and contact dermatitis.

28 Oct 2009

Nasopharyngeal Flocked Swabs are recommended for H1N1 and influenza A testing

Preparing for this flu season, the American Society for Microbiology (ASM) PSAB Committee on Laboratory Practices has recently published a new interim algorithm providing guidance to clinical laboratories responsible for testing patients with respiratory illness for Influenza A, including H1N1.

28 Oct 2009

Disease/Infection News

Comprehensive H1N1 influenza health information centre launched in Canada

AAHP confirms homeopathic medicines for prophylaxis of infectious diseases

NIH awards contract to LRRI for anthrax research

Pregnant women with symptoms of depression have a stronger biological reaction to the seasonal flu vaccine

GE Healthcare to provide surveillance data for H1N1 and seasonal influenza activity throughout the U.S.

$12.2 million grant from NIH for research on the sexually transmitted bacteria chlamydia

Scientists identify genetic mutations that may put individuals at increased risk of fungal infections

U.S. Department of Defense funds Rush University Medical Center for gastrointestinal microorganism research

NIH awards Excelimmune grant to develop treatment for Clostridium difficile infection

CDC says U.S. H1N1 vaccine supplies on the rise; Senators question government's handling of H1N1 vaccination program

Also in Global Health News: Germany HIV/AIDS grant; Sumatra water situation; India's unlicensed doctors; land ownership, food security

CDC: H1N1 vaccine supplies on the rise

Lovelace Respiratory Research Institute and Brigham and Women's Hospital collaborate on respiratory diseases research

FDA approves the 100th antiretroviral drug in association with PEPFAR

Innovative new partnership to provide free HIV testing and HIV/AIDS medical care in Saint-Petersburg

Fastest supercomputer used to create an evolutionary genetic HIV family tree

Dementia patients face higher risk of flu mortality; refine guidelines needed for testing and vaccination policies

Researchers find link between foreskin and HIV infection

Toxic chemicals in face paints can cause skin sensitization and contact dermatitis

Nasopharyngeal Flocked Swabs are recommended for H1N1 and influenza A testing

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Latest News